Skip to Main Content

Paper Details

Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study.
Clin Cancer Res
14
2022
Author NameAffiliation
John M S BartlettUniversity of Edinburgh
John M S BartlettOntario Institute of Cancer Research
Dennis C SgroiMassachusetts General Hospital
Tammy PiperUniversity of Edinburgh
Karen J TaylorUniversity of Edinburgh
Daniel ReaUniversity of Birmingham, Cancer Research UK Clinical Trials Unit
  • 1 - 6

Datasets

Release 1.2